IBDEI0Z7 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,15890,1,3,0)
;;=3^Exfoliative Dermatitis
;;^UTILITY(U,$J,358.3,15890,1,4,0)
;;=4^L26.
;;^UTILITY(U,$J,358.3,15890,2)
;;=^263886
;;^UTILITY(U,$J,358.3,15891,0)
;;=L27.0^^61^765^305
;;^UTILITY(U,$J,358.3,15891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15891,1,3,0)
;;=3^Skin Eruption d/t Drugs/Meds,Generalized
;;^UTILITY(U,$J,358.3,15891,1,4,0)
;;=4^L27.0
;;^UTILITY(U,$J,358.3,15891,2)
;;=^5009144
;;^UTILITY(U,$J,358.3,15892,0)
;;=L27.1^^61^765^306
;;^UTILITY(U,$J,358.3,15892,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15892,1,3,0)
;;=3^Skin Eruption d/t Drugs/Meds,Localized
;;^UTILITY(U,$J,358.3,15892,1,4,0)
;;=4^L27.1
;;^UTILITY(U,$J,358.3,15892,2)
;;=^5009145
;;^UTILITY(U,$J,358.3,15893,0)
;;=L29.0^^61^765^290
;;^UTILITY(U,$J,358.3,15893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15893,1,3,0)
;;=3^Pruritus Ani
;;^UTILITY(U,$J,358.3,15893,1,4,0)
;;=4^L29.0
;;^UTILITY(U,$J,358.3,15893,2)
;;=^100061
;;^UTILITY(U,$J,358.3,15894,0)
;;=L29.9^^61^765^291
;;^UTILITY(U,$J,358.3,15894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15894,1,3,0)
;;=3^Pruritus,Unspec
;;^UTILITY(U,$J,358.3,15894,1,4,0)
;;=4^L29.9
;;^UTILITY(U,$J,358.3,15894,2)
;;=^5009153
;;^UTILITY(U,$J,358.3,15895,0)
;;=L30.0^^61^765^270
;;^UTILITY(U,$J,358.3,15895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15895,1,3,0)
;;=3^Nummular Dermatitis
;;^UTILITY(U,$J,358.3,15895,1,4,0)
;;=4^L30.0
;;^UTILITY(U,$J,358.3,15895,2)
;;=^186823
;;^UTILITY(U,$J,358.3,15896,0)
;;=L30.1^^61^765^143
;;^UTILITY(U,$J,358.3,15896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15896,1,3,0)
;;=3^Dyshidrosis
;;^UTILITY(U,$J,358.3,15896,1,4,0)
;;=4^L30.1
;;^UTILITY(U,$J,358.3,15896,2)
;;=^5009154
;;^UTILITY(U,$J,358.3,15897,0)
;;=L30.2^^61^765^135
;;^UTILITY(U,$J,358.3,15897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15897,1,3,0)
;;=3^Cutaneous Autosensitization
;;^UTILITY(U,$J,358.3,15897,1,4,0)
;;=4^L30.2
;;^UTILITY(U,$J,358.3,15897,2)
;;=^5009155
;;^UTILITY(U,$J,358.3,15898,0)
;;=L30.4^^61^765^147
;;^UTILITY(U,$J,358.3,15898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15898,1,3,0)
;;=3^Erythema Intertrigo
;;^UTILITY(U,$J,358.3,15898,1,4,0)
;;=4^L30.4
;;^UTILITY(U,$J,358.3,15898,2)
;;=^5009157
;;^UTILITY(U,$J,358.3,15899,0)
;;=L30.8^^61^765^138
;;^UTILITY(U,$J,358.3,15899,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15899,1,3,0)
;;=3^Dermatitis NEC
;;^UTILITY(U,$J,358.3,15899,1,4,0)
;;=4^L30.8
;;^UTILITY(U,$J,358.3,15899,2)
;;=^5009158
;;^UTILITY(U,$J,358.3,15900,0)
;;=L30.9^^61^765^139
;;^UTILITY(U,$J,358.3,15900,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15900,1,3,0)
;;=3^Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,15900,1,4,0)
;;=4^L30.9
;;^UTILITY(U,$J,358.3,15900,2)
;;=^5009159
;;^UTILITY(U,$J,358.3,15901,0)
;;=L40.0^^61^765^293
;;^UTILITY(U,$J,358.3,15901,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15901,1,3,0)
;;=3^Psoriasis Vulgaris
;;^UTILITY(U,$J,358.3,15901,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,15901,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,15902,0)
;;=L40.1^^61^765^296
;;^UTILITY(U,$J,358.3,15902,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15902,1,3,0)
;;=3^Pustulosis Psoriasis,Generalized
;;^UTILITY(U,$J,358.3,15902,1,4,0)
;;=4^L40.1
;;^UTILITY(U,$J,358.3,15902,2)
;;=^5009161
;;^UTILITY(U,$J,358.3,15903,0)
;;=L40.2^^61^765^12
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Z7 3757 printed Oct 16, 2024@17:59:27 Page 2
IBDEI0Z7 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,15890,1,3,0)
+2 ;;=3^Exfoliative Dermatitis
+3 ;;^UTILITY(U,$J,358.3,15890,1,4,0)
+4 ;;=4^L26.
+5 ;;^UTILITY(U,$J,358.3,15890,2)
+6 ;;=^263886
+7 ;;^UTILITY(U,$J,358.3,15891,0)
+8 ;;=L27.0^^61^765^305
+9 ;;^UTILITY(U,$J,358.3,15891,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,15891,1,3,0)
+12 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
+13 ;;^UTILITY(U,$J,358.3,15891,1,4,0)
+14 ;;=4^L27.0
+15 ;;^UTILITY(U,$J,358.3,15891,2)
+16 ;;=^5009144
+17 ;;^UTILITY(U,$J,358.3,15892,0)
+18 ;;=L27.1^^61^765^306
+19 ;;^UTILITY(U,$J,358.3,15892,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,15892,1,3,0)
+22 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
+23 ;;^UTILITY(U,$J,358.3,15892,1,4,0)
+24 ;;=4^L27.1
+25 ;;^UTILITY(U,$J,358.3,15892,2)
+26 ;;=^5009145
+27 ;;^UTILITY(U,$J,358.3,15893,0)
+28 ;;=L29.0^^61^765^290
+29 ;;^UTILITY(U,$J,358.3,15893,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,15893,1,3,0)
+32 ;;=3^Pruritus Ani
+33 ;;^UTILITY(U,$J,358.3,15893,1,4,0)
+34 ;;=4^L29.0
+35 ;;^UTILITY(U,$J,358.3,15893,2)
+36 ;;=^100061
+37 ;;^UTILITY(U,$J,358.3,15894,0)
+38 ;;=L29.9^^61^765^291
+39 ;;^UTILITY(U,$J,358.3,15894,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,15894,1,3,0)
+42 ;;=3^Pruritus,Unspec
+43 ;;^UTILITY(U,$J,358.3,15894,1,4,0)
+44 ;;=4^L29.9
+45 ;;^UTILITY(U,$J,358.3,15894,2)
+46 ;;=^5009153
+47 ;;^UTILITY(U,$J,358.3,15895,0)
+48 ;;=L30.0^^61^765^270
+49 ;;^UTILITY(U,$J,358.3,15895,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,15895,1,3,0)
+52 ;;=3^Nummular Dermatitis
+53 ;;^UTILITY(U,$J,358.3,15895,1,4,0)
+54 ;;=4^L30.0
+55 ;;^UTILITY(U,$J,358.3,15895,2)
+56 ;;=^186823
+57 ;;^UTILITY(U,$J,358.3,15896,0)
+58 ;;=L30.1^^61^765^143
+59 ;;^UTILITY(U,$J,358.3,15896,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,15896,1,3,0)
+62 ;;=3^Dyshidrosis
+63 ;;^UTILITY(U,$J,358.3,15896,1,4,0)
+64 ;;=4^L30.1
+65 ;;^UTILITY(U,$J,358.3,15896,2)
+66 ;;=^5009154
+67 ;;^UTILITY(U,$J,358.3,15897,0)
+68 ;;=L30.2^^61^765^135
+69 ;;^UTILITY(U,$J,358.3,15897,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,15897,1,3,0)
+72 ;;=3^Cutaneous Autosensitization
+73 ;;^UTILITY(U,$J,358.3,15897,1,4,0)
+74 ;;=4^L30.2
+75 ;;^UTILITY(U,$J,358.3,15897,2)
+76 ;;=^5009155
+77 ;;^UTILITY(U,$J,358.3,15898,0)
+78 ;;=L30.4^^61^765^147
+79 ;;^UTILITY(U,$J,358.3,15898,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,15898,1,3,0)
+82 ;;=3^Erythema Intertrigo
+83 ;;^UTILITY(U,$J,358.3,15898,1,4,0)
+84 ;;=4^L30.4
+85 ;;^UTILITY(U,$J,358.3,15898,2)
+86 ;;=^5009157
+87 ;;^UTILITY(U,$J,358.3,15899,0)
+88 ;;=L30.8^^61^765^138
+89 ;;^UTILITY(U,$J,358.3,15899,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,15899,1,3,0)
+92 ;;=3^Dermatitis NEC
+93 ;;^UTILITY(U,$J,358.3,15899,1,4,0)
+94 ;;=4^L30.8
+95 ;;^UTILITY(U,$J,358.3,15899,2)
+96 ;;=^5009158
+97 ;;^UTILITY(U,$J,358.3,15900,0)
+98 ;;=L30.9^^61^765^139
+99 ;;^UTILITY(U,$J,358.3,15900,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,15900,1,3,0)
+102 ;;=3^Dermatitis,Unspec
+103 ;;^UTILITY(U,$J,358.3,15900,1,4,0)
+104 ;;=4^L30.9
+105 ;;^UTILITY(U,$J,358.3,15900,2)
+106 ;;=^5009159
+107 ;;^UTILITY(U,$J,358.3,15901,0)
+108 ;;=L40.0^^61^765^293
+109 ;;^UTILITY(U,$J,358.3,15901,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,15901,1,3,0)
+112 ;;=3^Psoriasis Vulgaris
+113 ;;^UTILITY(U,$J,358.3,15901,1,4,0)
+114 ;;=4^L40.0
+115 ;;^UTILITY(U,$J,358.3,15901,2)
+116 ;;=^5009160
+117 ;;^UTILITY(U,$J,358.3,15902,0)
+118 ;;=L40.1^^61^765^296
+119 ;;^UTILITY(U,$J,358.3,15902,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,15902,1,3,0)
+122 ;;=3^Pustulosis Psoriasis,Generalized
+123 ;;^UTILITY(U,$J,358.3,15902,1,4,0)
+124 ;;=4^L40.1
+125 ;;^UTILITY(U,$J,358.3,15902,2)
+126 ;;=^5009161
+127 ;;^UTILITY(U,$J,358.3,15903,0)
+128 ;;=L40.2^^61^765^12
